Showing results (2991-3000 of 9,335) with videos related to

Sort By:
Pageof 934
Cancer Medicine|February 27, 2025
circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLCWei Chen, Weijun Zhao, Xianqiao Wu, et al.
Cancer Medicine|February 27, 2025
CAR-T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of ViewSara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Cancer Medicine|February 18, 2025
Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective StudyChiyu Cai, Liancai Wang, Lianyuan Tao, et al.
Cancer Medicine|February 13, 2025
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle-Invasive Bladder Cancer in the United StatesBernard Bright Davies-Teye, M Minhaj Siddiqui, Xiao Zhang, et al.
Cancer Medicine|February 15, 2025
Social Determinants of Health Predict Sleep-Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross-Sectional AnalysisMichelle L Wright, Hope Miller, Elizabeth Vera, et al.
Cancer Medicine|February 14, 2025
Tumor Mutation Burden Survey of AACR GENIE Database Revealed NTRK (NTRK+) and RET (RET+) Fusions Positive Colorectal Carcinoma (CRC) as Distinct SubsetsZhaohui Liao Arter, Alexandria T M Lee, Misako Nagasaka, et al.
Cancer Medicine|February 14, 2025
The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally Advanced Cervical Cancer With Radiation-Induced LymphopeniaYi Li, Ao Liu, Xin Wang, et al.
Cancer Medicine|February 13, 2025
First-In-Human Dose Finding Study of Venadaparib (IDX-1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid TumorsSung-Bae Kim, Kyun-Seop Bae, Jae Lyun Lee, et al.
Cancer Medicine|February 11, 2025
Elevated Neutrophil-to-Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV MelanomaYannick Foerster, Kristine Mayer, Sophia Wasserer, et al.
Pageof 934